Directory
>
Matt Patricelli
Matt Patricelli
Director of Technology | Vividion Therapeutics, Inc.
California, San Diego, United States
Matt Patricelli
Summary
Matt Patricelli is an accomplished Chief Scientific Officer with over 20 years of expertise in enzymology, chemical biology, and drug discovery. He played a pivotal role in developing innovative chemical proteomics methodologies that significantly advanced drug development processes. As the biology lead for the KRAS-G12C program at Wellspring Biosciences, he achieved groundbreaking results in selective KRAS-G12C inhibition. Matt was also the first employee and founding scientist at Vividion Therapeutics, where he established a robust early discovery team and contributed to the company's success, culminating in a $2 billion acquisition by Bayer Pharmaceuticals. His extensive experience spans both startup environments and collaborations with major pharmaceutical companies. Matt is a prolific author with over 40 scientific publications and holds 6 patents, reflecting his deep commitment to advancing scientific knowledge and innovation.
Matt Patricelli
Work Experience
Chief Scientific Officer at
Vividion Therapeutics, Inc.
March 2023 - Present
Matt Patricelli
Education
The Scripps Research Institute, PhD, Biochemistry
January 1996 - January 2000
McGill University, BSc, Biochemistry
January 1992 - January 1996
Frequently Asked Questions about Matt Patricelli
What is Matt Patricelli email address?
Matt Patricelli's primary email address is *****@vividion.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Matt Patricelli work for?
Matt Patricelli is a Director of Technology at Vividion Therapeutics, Inc..
Where Matt Patricelli graduated from?
Matt Patricelli holds a degree in null from The Scripps Research Institute.
How can I directly contact Matt Patricelli?
To contact Matt Patricelli directly, you can use the email address *****@vividion.com. Complete contact information is available upon registration with Muraena.
Who is Matt Patricelli?
Matt Patricelli is an accomplished Chief Scientific Officer with over 20 years of expertise in enzymology, chemical biology, and drug discovery. He played a pivotal role in developing innovative chemical proteomics methodologies that significantly advanced drug development processes. As the biology lead for the KRAS-G12C program at Wellspring Biosciences, he achieved groundbreaking results in selective KRAS-G12C inhibition. Matt was also the first employee and founding scientist at Vividion Therapeutics, where he established a robust early discovery team and contributed to the company's success, culminating in a $2 billion acquisition by Bayer Pharmaceuticals. His extensive experience spans both startup environments and collaborations with major pharmaceutical companies. Matt is a prolific author with over 40 scientific publications and holds 6 patents, reflecting his deep commitment to advancing scientific knowledge and innovation.
Matt`s contact details
*****@vividion.com
Colleagues
Post doctoral fellow
Scientist
Sales Attendant
Post-Doctoral Fellow
Chemist
Undergraduate Research Associate
Associate
Head of Market Access
Clinical Research Associate
Audit Senior III